The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Incyte
Leadership - Incyte
Stock and Other Ownership Interests - Incyte
Patents, Royalties, Other Intellectual Property - Incysus
 
Employment - Incyte
Stock and Other Ownership Interests - Incyte
Phase I trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma multiforme.
 
Lawrence S. Lamb
Employment - Incyte
Leadership - Incyte
Stock and Other Ownership Interests - Incyte
Honoraria - Incyte
Consulting or Advisory Role - Incyte
Research Funding - Incyte
Patents, Royalties, Other Intellectual Property - Incysus
 
Shirley Gibbs
No Relationships to Disclose
 
Thriumaine Pillay
No Relationships to Disclose
 
Melissa Beelen
No Relationships to Disclose
 
William Ho
No Relationships to Disclose
 
Louis B. Nabors
Consulting or Advisory Role - Blue Earth Diagnostics; BTG; Karyopharm Therapeutics; KIYATEC